Brought to you by:
Shape Memory Medical completes enrollment in the AAA-SHAPE early feasibility study
Shape Memory Medical has announced the completion of patient enrollment in AAA-SHAPE, the company’s prospective, multicenter early feasibility safety study of the Impede-FX RapidFill device when used for abdominal aortic aneurysm (AAA) sac management during elective endovascular aneurysm repair (EVAR). The AAA-SHAPE…
Engaging with primary care providers ‘critically important’ to improving AAA screening
Matthew Mell, MD, has spent a lot of time looking into issues around screening for abdominal aortic aneurysms (AAAs). The problem, says the chief of vascular surgery at University of California Davis in Sacramento, California, is a difficult one to…
New data suggest patients at AAA repair thresholds can be safely deferred
Data from the PROVE-AAA cluster-randomized trial (Preferences for open versus endovascular repair of abdominal aortic aneurysm) of a novel decision aid to assist veterans decide between their options demonstrated that surgeons can safely defer AAA repair in patients with a…
Female sex is associated with reintervention and mortality following elective EVAR
Women are more likely to die within five years of having elective surgery to repair an abdominal aortic aneurysm (AAA) or need repeat surgery, according to a recent study. Writing in the Journal of Vascular Surgery, Taylor Corsi, BS, a medical student at Rutgers University, Piscataway,…
The top 10 most popular Vascular Specialist items of June 2022
June’s top stories spanned a range of presentations from the 2022 Vascular Annual Meeting (VAM) in Boston (June 15–18), covering topics including burnout among vascular surgeons, amputation rates in Black and Hispanic CLTI patients, and VAM’s inaugural Women’s Section education…
Artificial intelligence can predict risk of complications after endovascular aneurysm repair
Artificial intelligence (AI) models can be developed to predict the risk of postoperative complications after endovascular aneurysm repair (EVAR) with “high accuracy,” research presented at the 2022 Vascular Annual Meeting (VAM) in Boston (June 15–18) demonstrated. “Complications after EVAR can…
Cydar Medical and King’s College London partner on randomized controlled trial of Cydar EV Maps
Cydar Medical has partnered with King’s College London to initiate the ARIA study—a randomized controlled trial to assess the clinical-, technical- and cost-effectiveness of a cloud-based, artificially intelligent image fusion system in comparison to standard treatment to guide endovascular aortic…
Greenberg Lecture raises prospect that ‘less is more and more is less’ with aortic disease treatment
Jan S. Brunkwall, MD, from the University of Cologne in Cologne, Germany, delivered the Roy Greenberg Distinguished Lecture at the 2022 Vascular Annual Meeting (VAM), telling attendees “more is less, and less is more!” when it comes to treatment for…
Open repair of infrarenal aortic aneurysm proves preferable to endovascular repair
As part of the Vascular Annual Meeting (VAM) International Fast Talk session on the morning of Wednesday, June 15, Emiliano Chisci, MD, from San Giovanni di Dio Hospital in Florence, Italy, will be presenting the results of a 15-year follow-up…
The top 10 most popular Vascular Specialist stories in May 2022
News on the Society for Vascular Surgery (SVS) ballots set to determine the next vice president and secretary, a hard-hitting column about vascular surgery’s role in treating vascular injury, and a look inside the most recent issue of Seminars in…